Sažetak sa skupa
https://doi.org/10.21857/ypn4oc4189
News in the prevention and treatment of stroke
Vida Demarin
; International Institute for Brain Health, Zagreb
Hrvoje Budinčević
orcid.org/0000-0002-0184-8949
; Sveti Duh University Hospital, Department of Neurology, Zagreb
*
Barbara Čaić
; Sveti Duh University Hospital, Department of Neurology, Zagreb
Hrvoje Jurlina
orcid.org/0009-0000-0909-6107
; Health Center of Zagreb County, Velika Gorica
* Dopisni autor.
Sažetak
The leading cause of disability and mortality in Croatia and the world is stroke. Up to 90% of strokes
can be prevented if ten modifiable risk factors are controlled. Stroke treatment has made significant
progress in the last twenty years, primarily with mechanical thrombectomy, systemic thrombolysis, and
other supportive measures in stroke units. Treatment in specialized stroke units increases the probability
of a good outcome by 14%, the use of systemic thrombolysis by 30%, and mechanical thrombectomy
by more than 50%.
This lecture aims to present news in research on stroke prevention and treatment, including the following
research funded by the European Union: Validate, Umbrella, TRUSTroke, RES-Q+, POC4Triage,
and EAST Stroke. These projects use artificial intelligence and/or advanced technology to improve
stroke care from different angles.
Validate project uses artificial intelligence to revolutionize stroke treatment by analyzing patient data
and helping physicians make faster, more informed decisions. To make artificial intelligence a reliable
medical tool, VALIDATE focuses on 1) training artificial intelligence with diverse data to reduce bias,
2) collaborating with physicians, artificial intelligence experts, and patients, 3) following EU safety
and ethical regulations, and 4) continuously testing for accuracy and reliability. The UMBRELLA
project will use advanced technology, artificial intelligence, and real patient data to help physicians
make better treatment decisions, improve recovery, and prevent future strokes. The UMBRELLA aims
to improve stroke care by 1) faster diagnosis & treatment, 2) personalized care, 3) better access to care,
and 4) understanding unknown strokes. The RES-Q+ project aims to improve the quality of stroke
care by combining artificial intelligence with stroke data. RES-Q+ project will use technology to 1)
automatically collect hospital data, 2) AI-powered virtual assistant tools will help physicians assess risks
and improve treatment plans, 3) support recovery by tracking progress, and 4) provide information
and ensure access to post-stroke care and rehabilitation. TRUSTroke project uses artificial intelligence
to improve stroke recovery by helping predict future health risks. TRUSTroke project aims to develop
an AI-driven system (easy-to-use application) to personalize treatment and reduce risks such as serious
post-stroke health issues, mobility challenges, and recurring strokes.
The EAST-STROKE trial (‘Early treatment of Atrial fibrillation for Stroke prevention Trial in acute
STROKE’) tests a new treatment strategy (rhythm control) for patients with acute ischemic stroke
and atrial fibrillation. The EAST-STROKE trial aims to change that by integrating this treatment early
after a stroke alongside standard care. The POC4Triage project will use advanced technology and
artificial intelligence to improve the speed and accuracy of diagnosis in stroke and other cardiorespiratory
conditions. POC4Triage is developing four innovative, portable medical devices designed to
provide information for ambulance professionals and physicians to make faster treatment decisions in
patients with acute stroke. These portable medical devices are 1) multi-diagnostic monitoring patch,
2) electroencephalography patch, 3) functional near-infrared spectroscopy (fNIRS) device for stroke
monitoring, and 4) handheld blood test device (for biomarkers). The four devices will connect to a
device hospital connectivity platform.
Ključne riječi
stroke, stroke prevention, stroke treatment, trials
Hrčak ID:
333473
URI
Datum izdavanja:
25.6.2025.
Posjeta: 406 *